Clear-cell cancer of the ovary?is it chemosensitive?

Selvan Pather, S Pather, M A Quinn, Michael Quinn
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2005 · vol. 15(3) , pp. 432–437 · doi:10.1111/j.1525-1438.2005.15305.x · PMID:15882166 · W2032026377
article OA: closed CC0 ⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper investigates the chemosensitivity of clear-cell ovarian cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma, Clear Cell Antineoplastic Combined Chemotherapy Protocols Ovarian Neoplasms Adenocarcinoma, Clear Cell Adult Aged Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols Carboplatin Carboplatin Drug Resistance, Neoplasm Endometriosis Female Humans Middle Aged Neoplasm Recurrence, Local Neoplasm Staging Ovarian Neoplasms Paclitaxel Paclitaxel

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (5)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:41.664291+00:00
License: CC0 · commercial use OK